Ghana vs Rwanda: HIV/AIDS deaths averted by antiretroviral therapy
Ghana
12,358 deaths
in 2024
Rwanda
13,299 deaths
in 2024
Ghana rank
20th
Rwanda rank
18th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Ghana
- Rwanda
How they compare
Rwanda currently reports 13,299 deaths against 12,358 deaths in Ghana, a difference of 941 deaths.
That makes Rwanda's figure about 1.1 times Ghana's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Rwanda ahead.
Ghana ranks 20th and Rwanda ranks 18th of 157 countries.
Rwanda has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Ghana | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,525 deaths | 3,990 deaths | 2,464 deaths | Rwanda |
| 2010s | 9,063 deaths | 12,999 deaths | 3,937 deaths | Rwanda |
| 2020s | 11,466 deaths | 13,654 deaths | 2,188 deaths | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Ghana or Rwanda?
- Rwanda, at 13,299 deaths against 12,358 deaths in Ghana as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Ghana and Rwanda?
- 941 deaths, with Rwanda ahead.
- How many years of comparable data are there for Ghana and Rwanda?
- 35 years are reported by both, from 1990 to 2024.
- How do Ghana and Rwanda rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Ghana ranks 20th and Rwanda ranks 18th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.